Compare MFIC & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MFIC | ALVO |
|---|---|---|
| Founded | 2004 | 2013 |
| Country | United States | Luxembourg |
| Employees | N/A | 1032 |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | N/A | N/A |
| Metric | MFIC | ALVO |
|---|---|---|
| Price | $10.42 | $3.63 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $11.25 | $9.25 |
| AVG Volume (30 Days) | ★ 1.3M | 667.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 12.00% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $20.22 |
| Revenue Next Year | N/A | $37.22 |
| P/E Ratio | ★ $10.50 | $18.20 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.48 | $3.45 |
| 52 Week High | $13.51 | $11.85 |
| Indicator | MFIC | ALVO |
|---|---|---|
| Relative Strength Index (RSI) | 45.00 | 32.66 |
| Support Level | $9.48 | N/A |
| Resistance Level | $11.74 | $4.17 |
| Average True Range (ATR) | 0.40 | 0.19 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 63.18 | 24.22 |
MidCap Financial Investment Corp is an externally managed, publicly traded, closed-end, diversified management investment company. Its investment objective is to generate current income and, to a lesser extent, long-term capital appreciation. It predominantly invests in directly originated and privately negotiated first lien senior secured loans to privately held U.S. middle-market companies, and in other types of securities including, first lien unitranche, second lien senior secured, unsecured, subordinated, and mezzanine loans, and equities in both private and public middle market companies.
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.